183 related articles for article (PubMed ID: 11401729)
21. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
[TBL] [Abstract][Full Text] [Related]
22. Once-a-month injectable contraceptives.
d'Arcangues C
World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
[TBL] [Abstract][Full Text] [Related]
23. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
25. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
26. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
27. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
[TBL] [Abstract][Full Text] [Related]
28. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
Balogun OR; Raji HO
Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
[TBL] [Abstract][Full Text] [Related]
29. When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate?
Paulen ME; Curtis KM
Contraception; 2009 Oct; 80(4):391-408. PubMed ID: 19751863
[TBL] [Abstract][Full Text] [Related]
30. Facts about injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
[TBL] [Abstract][Full Text] [Related]
31. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
33. Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa.
Smith JA; Beacroft L; Abdullah F; Buthelezi B; Makua M; Morroni C; Ramjee G; Velasquez C; Hallett TB
J Int AIDS Soc; 2020 Oct; 23(10):e25620. PubMed ID: 33030312
[TBL] [Abstract][Full Text] [Related]
34. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
Matubu AT; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
Am J Reprod Immunol; 2021 Jul; 86(1):e13405. PubMed ID: 33609312
[TBL] [Abstract][Full Text] [Related]
35. Use of injectable progestin contraception and risk of STI among South African women.
Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
[TBL] [Abstract][Full Text] [Related]
36. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Schulz KF; d'Arcangues C; Lopez LM
Cochrane Database Syst Rev; 2005 Jul; (3):CD004568. PubMed ID: 16034938
[TBL] [Abstract][Full Text] [Related]
37. Long acting injectable hormonal contraceptives.
Fraser IS
Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
39. Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria.
Adeyemi AS; Adekanle DA
Ann Afr Med; 2012; 11(1):27-31. PubMed ID: 22199044
[TBL] [Abstract][Full Text] [Related]
40. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
Matubu A; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
Am J Reprod Immunol; 2020 Mar; 83(3):e13210. PubMed ID: 31729087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]